期刊
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
卷 42, 期 12, 页码 1060-1065出版社
SAGE PUBLICATIONS LTD
DOI: 10.1080/00048670802512016
关键词
atypical neuroleptics; cannabis; dual diagnosis; schizophrenia; self-medication hypothesis; substance use
类别
资金
- Swiss Federal Office of Public Health [02.001033]
Objective: The aim of the present study was to compare self-reported reasons for cannabis use in patients with schizophrenia with those of matched healthy controls. Methods: Thirty-six stable outpatients with schizophrenia treated with atypical antipsychotics and 36 matched controls were included. They completed a questionnaire exploring 15 common reasons for use, established in other studies. Results: Overall, patients more frequently agreed with the proposed reasons for use than controls. More specifically, patients with schizophrenia more often stated that they consumed cannabis to fight boredom and to ease social contacts. Conclusions: Stable schizophrenia outpatients treated with atypicals do not use cannabis in order to reduce side-effects of medication or symptoms of their disorder. Rather, they used cannabis to overcome a feeling of social exclusion. Therefore, enhancing social participation of cannabis-using patients might be an effective strategy for reducing consumption.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据